文献速递神经肿瘤

胶质瘤补充与替代医学治疗:临床研究、患者结局与毒性范围综述

Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles.
PubMed 文献 · World Neurosurg · 2021-04-30

多数CAM疗法缺乏高级别证据,生酮饮食、高压氧和大麻素初步显示安全且可能联合标准治疗改善生存,而卡波金呼吸和低铜血症无效且毒性显著。

要点

  • 生酮饮食、高压氧和大麻素初步显示安全且可能改善生存。
  • 抗氧化剂效果不一,维生素D摄入与生存延长相关。
  • 卡波金呼吸和低铜血症无效且毒性显著。

核心结论

  • 尽管CAM在胶质瘤患者中广泛使用,但缺乏I或II级证据,需进一步研究以优化咨询和治疗。

主要发现

  • 生酮饮食、高压氧和大麻素初步显示安全且耐受良好,联合标准治疗可见肿瘤反应及无进展生存和总生存改善。
  • 抗氧化剂效果不一,可能与胶质瘤级别相关,对低级别胶质瘤效果更大;维生素D摄入与生存延长相关。
  • 卡波金呼吸和低铜血症对胶质瘤患者生存无影响,且伴有显著毒性。

临床怎么用

  • 临床医生应了解CAM证据级别低,对患者咨询时需明确区分未证实、已 disproven 或有前景的CAM实践。

局限性

  • 大多数CAM模式未经适当研究,缺乏I或II级证据,需进一步调查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Complementary and alternative medicine (CAM) are highly used among those diagnosed with glioma. Further research is warranted, however, as it remains important to clearly delineate CAM practices that are unproven, disproven, or promising for future research and implementation. METHODS: A systematic review was conducted to identify all articles that investigated the effect of any CAM therapy on survival of patients with newly diagnosed or recurrent glioma. RESULTS: Eighteen papers and 4 abstracts pertaining to the effects of ketogenic diet (4), antioxidants (3), hyperbaric oxygen (4), cannabinoids (2), carbogen and nicotinamide (3), mistletoe extract (2), hypocupremia and penicillamine (1), and overall CAM use (3) on overall and progression-free survival in patients with low- and high-grade glioma were identified (Levels of Evidence I-IV). Ketogenic diets, hyperbaric oxygen therapy, and cannabinoids appear to be safe and well tolerated by patients; preliminary studies demonstrate tumor response and increased progression-free survival and overall survival when combined with standard of care therapies. Antioxidant usage exhibit mixed results perhaps associated with glioma grade with greater effect on low-grade gliomas; vitamin D intake was associated with prolonged survival. Conversely, carbogen breathing and hypocupremia were found to have no effect on the survival of patients with glioma, with associated significant toxicity. Most modalities under the CAM umbrella have not been appropriately studied and require further investigation. CONCLUSIONS: Despite widespread use, Level I or II evidence for CAM for the treatment of glioma is lacking, representing future research directions to optimally counsel and treat glioma patients.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pangal DJ, Baertsch H, Kellman EM, et al. Complementary and Alternative Medicine for the Treatment of Gliomas: Scoping Review of Clinical Studies, Patient Outcomes, and Toxicity Profiles. World Neurosurg. 2021. PMID: 33940275. doi:10.1016/j.wneu.2021.04.096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。